GO:0030876 interleukin-20 receptor complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030876 (interleukin-20 receptor complex) is a heteromeric cell-surface receptor complex composed of alpha and beta subunits that binds IL-19, IL-20, and IL-24 cytokines.
• Two major receptor complexes exist: IL20RA/IL20RB (type I) and IL22RA1/IL20RB (type II), which mediate overlapping but distinct signaling.
• The complex signals through JAK-STAT pathways to regulate inflammation, proliferation, and tissue remodeling.
• Dysregulation of the IL-20 receptor axis is implicated in autoimmune diseases including psoriasis, rheumatoid arthritis, and inflammatory bowel disease.
• Structural studies reveal that IL-20R2 (IL20RB) is a shared subunit that binds multiple cytokines with distinct affinities.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting receptor subunit-specific functions in disease.
Description
The interleukin-20 receptor complex (GO:0030876) is a heterodimeric cell-surface receptor that mediates signaling by the IL-20 subfamily of cytokines, which includes IL-19, IL-20, and IL-24. This receptor complex is a critical component of the immune system's communication network, translating extracellular cytokine signals into intracellular responses that regulate inflammation, cell proliferation, and tissue homeostasis. Unlike many cytokine receptors that form homodimers, the IL-20 receptor complex is defined by its combinatorial assembly of alpha and beta subunits, creating two distinct signaling platforms: the type I complex (IL20RA/IL20RB) and the type II complex (IL22RA1/IL20RB). This structural flexibility allows a limited number of cytokines to exert pleiotropic effects across different cell types and tissues. Researchers study GO:0030876 because its dysregulation is increasingly linked to human disease. Genome-wide association studies and functional analyses have implicated IL-20 receptor components in autoimmune conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. The receptor complex also plays roles in epithelial barrier function, wound healing, and host defense. Understanding the precise molecular architecture and signaling mechanisms of this complex is essential for developing targeted therapeutics that can modulate specific receptor subunits without disrupting related pathways. The interleukin-20 receptor complex is a prime example of how receptor sharing and combinatorial assembly generate signaling diversity. Structural and biochemical studies have revealed that the shared beta subunit, IL20RB, can pair with either IL20RA or IL22RA1 to form functional receptors with different ligand specificities and downstream effects. This complexity makes the IL-20 receptor axis an attractive but challenging target for drug discovery, requiring sophisticated experimental models to dissect subunit-specific contributions.
interleukin-20 receptor complex At A Glance
| GO ID | GO:0030876 |
|---|---|
| GO term | interleukin-20 receptor complex |
| Ontology | cellular_component |
| Synonym | IL-20 receptor complex |
| Definition | A protein complex composed of an alpha and a beta receptor subunit and an interleukin ligand. In human, Interleukin-19, -20 and -24 bind IL20RA/IL20RB receptor subunits and Interleukin-20 and -24 bind IL22RA1/IL20RB receptor subunits. |
| Major function | Mediates signaling by IL-19, IL-20, and IL-24 cytokines to regulate inflammation, proliferation, and tissue homeostasis. |
| Subunits | Alpha subunits: IL20RA, IL22RA1; Beta subunit: IL20RB. |
| Ligands | IL-19, IL-20, IL-24. |
| Signaling pathway | JAK-STAT pathway activation. |
| Cellular location | Plasma membrane. |
What Is GO:0030876?
The interleukin-20 receptor complex (GO:0030876) is a protein complex located at the cell surface that consists of an alpha receptor subunit and a beta receptor subunit bound to an interleukin ligand. In humans, this complex is formed when cytokines such as IL-19, IL-20, or IL-24 bind to the alpha subunit (either IL20RA or IL22RA1) and the beta subunit (IL20RB). Specifically, IL-19, IL-20, and IL-24 can bind the IL20RA/IL20RB heterodimer, while IL-20 and IL-24 bind the IL22RA1/IL20RB heterodimer. This definition captures the combinatorial nature of the receptor, where different ligand-receptor combinations produce distinct signaling outcomes.
Why Is interleukin-20 receptor complex Important in Cell Biology?
The interleukin-20 receptor complex is critically important because it serves as the primary gateway for IL-20 subfamily cytokine signaling, which orchestrates inflammatory responses, epithelial cell proliferation, and tissue repair. Dysregulation of this receptor complex is directly implicated in the pathogenesis of major autoimmune and inflammatory diseases, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Furthermore, the receptor complex is a promising therapeutic target, with monoclonal antibodies and small molecule inhibitors designed to block specific subunit interactions currently under investigation. Understanding the precise composition and assembly of GO:0030876 is therefore essential for both basic immunology and translational medicine.
• Mediates signaling of IL-19, IL-20, and IL-24, key cytokines in autoimmune and inflammatory diseases.
• Forms two distinct receptor complexes (IL20RA/IL20RB and IL22RA1/IL20RB) with overlapping ligand specificities.
• Activates JAK-STAT signaling to regulate gene expression programs controlling inflammation and proliferation.
• Implicated in psoriasis pathogenesis through increased expression in keratinocytes.
• Associated with rheumatoid arthritis severity and radiographic progression.
• Plays a role in trabecular meshwork cell signaling relevant to glaucoma.
• Serves as a target for therapeutic antibodies in autoimmune diseases.
• Structural studies provide a basis for rational drug design targeting receptor-ligand interfaces.
• Involved in epithelial barrier function and host defense mechanisms.
• Provides a model system for studying cytokine receptor sharing and combinatorial signaling.
Structure and Composition of interleukin-20 receptor complex
Alpha and Beta Subunit Heterodimerization
In simple terms: The receptor is made of two different protein chains that pair up to form a functional unit.
The interleukin-20 receptor complex is a heterodimeric assembly composed of an alpha subunit and a beta subunit. The alpha subunit can be either IL20RA or IL22RA1, while the beta subunit is consistently IL20RB (also known as IL-20R2). This heterodimerization is essential for ligand binding and signal transduction. Structural studies have shown that the extracellular domains of these subunits form a composite binding site that accommodates the cytokine ligand with high specificity. The alpha subunit determines which cytokines can bind, while the beta subunit is shared among different receptor complexes, allowing for combinatorial diversity.
Ligand Binding and Receptor Activation
In simple terms: Cytokines bind to the receptor like a key in a lock, triggering a signal inside the cell.
The interleukin-20 receptor complex binds specific cytokines of the IL-10 family. IL-19, IL-20, and IL-24 bind to the IL20RA/IL20RB complex, while IL-20 and IL-24 bind to the IL22RA1/IL20RB complex. Ligand binding induces conformational changes in the receptor subunits that bring the intracellular domains into proximity, facilitating the activation of associated Janus kinases (JAKs). This activation leads to phosphorylation of the receptor intracellular domains and subsequent recruitment of STAT transcription factors. The specificity of ligand binding is determined by the alpha subunit, with IL20RA and IL22RA1 exhibiting distinct but overlapping binding profiles.
JAK-STAT Signal Transduction
In simple terms: The receptor activates a signaling cascade that turns on specific genes in the nucleus.
Upon ligand binding, the interleukin-20 receptor complex activates the JAK-STAT signaling pathway. JAK kinases associated with the receptor subunits phosphorylate tyrosine residues on the receptor intracellular domains, creating docking sites for STAT proteins. STAT proteins are then phosphorylated, dimerize, and translocate to the nucleus where they regulate transcription of target genes involved in inflammation, proliferation, and differentiation. The specific STAT molecules activated (e.g., STAT1, STAT3) can vary depending on the cell type and the specific receptor complex engaged, contributing to the pleiotropic effects of IL-20 family cytokines.
Receptor Complex Internalization and Regulation
In simple terms: After signaling, the receptor is taken into the cell and either recycled or degraded to stop the signal.
Following activation, the interleukin-20 receptor complex undergoes internalization and downregulation. This process is tightly regulated to prevent excessive or prolonged signaling, which can contribute to chronic inflammation. The dynamics of receptor expression and internalization are cell-type specific and can be altered in disease states such as psoriasis, where increased receptor levels are observed. Understanding these regulatory mechanisms is important for developing therapeutic strategies that target the receptor complex.
Key Genes Involved in GO:0030876 interleukin-20 receptor complex
The following genes encode the subunits, ligands, and signaling molecules associated with the interleukin-20 receptor complex (GO:0030876).
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL20RA | Alpha subunit of type I IL-20 receptor complex | Binds IL-19, IL-20, IL-24; target for autoimmune disease research |
| IL20RB | Beta subunit shared by both receptor complexes | Common subunit for IL20RA and IL22RA1; structural studies |
| IL22RA1 | Alpha subunit of type II IL-20 receptor complex | Binds IL-20 and IL-24; involved in epithelial signaling |
| IL19 | Cytokine ligand for IL20RA/IL20RB complex | Regulates inflammation; implicated in psoriasis |
| IL20 | Cytokine ligand for both receptor complexes | Key mediator of inflammation and proliferation |
| IL24 | Cytokine ligand for both receptor complexes | Regulates cell survival and apoptosis |
| JAK1 | Janus kinase associated with receptor subunits | Phosphorylates receptor and STAT proteins |
| JAK2 | Janus kinase associated with receptor subunits | Mediates signal transduction |
| TYK2 | Janus kinase associated with receptor subunits | Contributes to IL-20 receptor signaling |
| STAT1 | Transcription factor activated by receptor signaling | Regulates inflammatory gene expression |
| STAT3 | Transcription factor activated by receptor signaling | Controls proliferation and survival genes |
| STAT5 | Transcription factor activated by receptor signaling | Modulates immune responses |
| SOCS1 | Negative regulator of JAK-STAT signaling | Feedback inhibition of receptor signaling |
| SOCS3 | Negative regulator of JAK-STAT signaling | Attenuates IL-20 receptor signaling |
| PIAS3 | Protein inhibitor of activated STAT | Modulates STAT3 activity downstream of receptor |
| SHP2 | Protein tyrosine phosphatase | Regulates receptor signaling amplitude |
How Is interleukin-20 receptor complex Regulated?
The interleukin-20 receptor complex is regulated at multiple levels. Expression of the receptor subunits IL20RA, IL22RA1, and IL20RB is controlled by cytokines and growth factors, with increased expression observed in inflamed tissues. At the protein level, receptor signaling is attenuated by negative feedback mechanisms involving SOCS proteins and phosphatases that dephosphorylate JAKs and STATs. Additionally, receptor internalization and degradation limit the duration of signaling. The balance between activating and inhibitory signals determines the cellular response to IL-20 family cytokines, and disruption of this balance contributes to autoimmune pathology.
interleukin-20 receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL20RA | Psoriasis, rheumatoid arthritis | Keratinocyte knockout and overexpression models |
| IL20RB | Autoimmune diseases, glaucoma | Trabecular meshwork cell knockout models |
| IL22RA1 | Inflammatory bowel disease, psoriasis | Intestinal epithelial cell knock-in models |
| IL20 | Rheumatoid arthritis, psoriasis | Synovial fibroblast overexpression models |
| IL24 | Cancer, autoimmune diseases | Tumor cell line knockout models |
Psoriasis and Inflammatory Skin Diseases
The interleukin-20 receptor complex is strongly implicated in psoriasis, a chronic inflammatory skin disease. Expression of IL-19, IL-20, and their receptors is upregulated in psoriatic lesions, and this correlates with disease severity. The receptor complex mediates keratinocyte hyperproliferation and aberrant differentiation, hallmark features of psoriasis. Therapeutic strategies targeting the IL-20 receptor axis are being explored for psoriasis treatment.
Rheumatoid Arthritis
In rheumatoid arthritis, the IL-20 receptor axis is associated with disease progression and radiographic damage. Elevated levels of IL-20 and its receptors are found in synovial tissue, and the receptor complex contributes to synovial inflammation and bone erosion. The presence of disease-associated autoantibodies correlates with IL-20 receptor axis activity, suggesting a link between autoimmunity and cytokine signaling.
Ocular and Trabecular Meshwork Biology
The interleukin-20 receptor complex is expressed in trabecular meshwork cells of the eye, where it regulates aqueous humor outflow and intraocular pressure. Cytokine signaling through this receptor complex affects trabecular meshwork cell function and may contribute to glaucoma pathogenesis. These findings highlight the importance of the receptor complex beyond classical immune tissues.
Inflammatory Bowel Disease and Other Autoimmune Conditions
The IL-20 receptor complex has been implicated in inflammatory bowel disease and other autoimmune conditions. IL-20 and IL-24 signaling through the receptor complex promotes epithelial barrier dysfunction and chronic inflammation. Targeting the receptor complex or its ligands may offer therapeutic benefits in these diseases.
From interleukin-20 receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IL20RA mediate IL-19-induced signaling? | IL20RA knockout cell line |
| What is the role of IL20RB in receptor assembly? | IL20RB point mutation knock-in |
| How does IL22RA1 contribute to epithelial barrier function? | IL22RA1 knockout organoids |
| Can tagged IL20RA track receptor internalization? | Tagged knock-in of IL20RA |
| Does overexpression of IL-20 drive inflammation? | IL20 overexpression in keratinocytes |
| What genes are regulated by IL-20 receptor signaling? | CRISPR library screening with receptor knockout |
How to Study the interleukin-20 receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR-Cas9 knockout | Loss of receptor subunit function | Identifying subunit-specific signaling |
| RNA sequencing | Transcriptional changes | Profiling target genes of receptor signaling |
| Proteomics | Protein expression and modifications | Detecting phosphorylated signaling intermediates |
| X-ray crystallography | Three-dimensional structure | Mapping ligand-receptor interfaces |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying cytokine-receptor interactions |
| Immunohistochemistry | Tissue expression patterns | Localizing receptor subunits in disease tissues |
| Flow cytometry | Cell surface receptor levels | Measuring receptor internalization and downregulation |
| CRISPR library screening | Genome-wide functional interactions | Identifying modifiers of receptor signaling |
CRISPR-Cas9 Knockout Studies
CRISPR-Cas9 knockout of individual receptor subunits (IL20RA, IL20RB, IL22RA1) allows researchers to dissect subunit-specific functions. Knockout cell lines can be used to determine which ligands signal through which receptor complexes and to identify downstream target genes. This approach is particularly valuable for studying the combinatorial complexity of the IL-20 receptor axis.
Transcriptomic and Proteomic Profiling
RNA sequencing and proteomics can be used to profile gene expression changes following receptor activation or knockout. These methods identify signaling pathways and target genes regulated by the interleukin-20 receptor complex, providing insights into its role in inflammation and proliferation. Comparative analysis of different receptor subunit knockouts reveals distinct and overlapping functions.
Structural and Biophysical Approaches
Structural studies using X-ray crystallography and molecular modeling have elucidated the binding interfaces between IL-20 family cytokines and their receptor subunits. These approaches provide atomic-level details of receptor-ligand interactions and inform the design of therapeutic inhibitors. Biophysical techniques such as surface plasmon resonance measure binding affinities and kinetics.
In Vivo Disease Models
Animal models of autoimmune diseases, including psoriasis-like dermatitis and arthritis models, are used to study the role of the interleukin-20 receptor complex in pathogenesis. These models allow evaluation of receptor-targeted therapeutics and provide translational relevance. Perfusion culture systems of anterior segment tissues have been used to study receptor signaling in ocular biology.
How CRISPR Can Be Used to Study GO:0030876 interleukin-20 receptor complex
Knockout
CRISPR knockout of IL20RA, IL20RB, or IL22RA1 generates cell lines that lack specific receptor subunits, enabling researchers to determine which cytokines signal through which complexes. For example, IL20RA knockout cells are unresponsive to IL-19, while IL22RA1 knockout cells are unresponsive to IL-20 and IL-24. These models are essential for dissecting the combinatorial complexity of the IL-20 receptor axis.
Point Mutation
Point mutations can be introduced into receptor subunits to disrupt specific binding interfaces or signaling motifs. For instance, mutating tyrosine residues in the intracellular domain of IL20RB can prevent STAT recruitment without affecting ligand binding. Such models help map the precise molecular determinants of receptor function.
Knock-in
Knock-in of tagged receptor subunits (e.g., GFP or HA tags) allows real-time tracking of receptor localization, internalization, and trafficking. Tagged IL20RA or IL20RB can be used to study receptor dynamics in live cells and to identify interacting proteins by co-immunoprecipitation. Knock-in models also enable the study of disease-associated mutations in their native genomic context.
Overexpression
Overexpression of IL-20 family cytokines or receptor subunits can model the increased signaling observed in autoimmune diseases. For example, overexpression of IL-20 in keratinocytes recapitulates features of psoriasis. Overexpression models are useful for screening therapeutic inhibitors and for studying the consequences of chronic receptor activation.
How EDITGENE Supports interleukin-20 receptor complex Research
Researchers studying interleukin-20 receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, disease pathogenesis, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models that address these questions.
Contact EDITGENE today to design your custom CRISPR model for interleukin-20 receptor complex research.
Frequently Asked Questions About interleukin-20 receptor complex
What is the interleukin-20 receptor complex?
The interleukin-20 receptor complex (GO:0030876) is a heterodimeric cell-surface receptor composed of an alpha subunit (IL20RA or IL22RA1) and a beta subunit (IL20RB) that binds IL-19, IL-20, and IL-24 cytokines.
What genes are involved in the interleukin-20 receptor complex?
The key genes are IL20RA, IL20RB, and IL22RA1, which encode the receptor subunits, and IL19, IL20, and IL24, which encode the ligands.
What diseases are associated with the interleukin-20 receptor complex?
It is associated with psoriasis, rheumatoid arthritis, inflammatory bowel disease, and ocular conditions such as glaucoma.
How does the interleukin-20 receptor complex signal?
It activates the JAK-STAT pathway, leading to phosphorylation of STAT transcription factors that regulate gene expression.
What is the difference between type I and type II IL-20 receptor complexes?
Type I uses IL20RA/IL20RB and binds IL-19, IL-20, and IL-24; type II uses IL22RA1/IL20RB and binds IL-20 and IL-24.
How can I study the interleukin-20 receptor complex using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models can be used to dissect subunit-specific functions and signaling mechanisms.
What is the role of IL20RB in the receptor complex?
IL20RB is the shared beta subunit that pairs with either IL20RA or IL22RA1 to form functional receptor complexes.
Is the interleukin-20 receptor complex a therapeutic target?
Yes, it is being explored as a target for autoimmune diseases, with antibodies and inhibitors under development.
What cell types express the interleukin-20 receptor complex?
It is expressed in keratinocytes, synovial fibroblasts, trabecular meshwork cells, and various epithelial and immune cells.
What are the research methods for studying the interleukin-20 receptor complex?
Common methods include CRISPR knockout, RNA sequencing, proteomics, structural biology, and in vivo disease models.
Conclusion
The interleukin-20 receptor complex (GO:0030876) is a central mediator of IL-20 subfamily cytokine signaling, with critical roles in inflammation, tissue homeostasis, and autoimmune disease pathogenesis. Its combinatorial assembly from alpha and beta subunits creates signaling diversity that is essential for understanding how a limited number of cytokines can exert pleiotropic effects. Continued research using advanced CRISPR models and structural approaches will further elucidate the molecular mechanisms of this receptor complex and facilitate the development of targeted therapeutics for diseases such as psoriasis and rheumatoid arthritis.
References
- 1. Chen J et al.. 2018. IL-20 receptor cytokines in autoimmune diseases.. J Leukoc Biol 104(5):953-959 PMID: 30260500
- 2. Keller KE et al.. 2019. Analysis of interleukin-20 receptor complexes in trabecular meshwork cells and effects of cytokine signaling in anterior segment perfusion culture.. Mol Vis 25:266-282 PMID: 31205408
- 3. Logsdon NJ et al.. 2012. Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines.. Proc Natl Acad Sci U S A 109(31):12704-9 PMID: 22802649
- 4. Kragstrup TW et al.. 2016. The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.. Arthritis Res Ther 18:61 PMID: 26968800
- 5. Preimel D et al.. 2004. Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.. J Mol Model 10(4):290-6 PMID: 15243778
- 6. Wegenka UM. 2010. IL-20: biological functions mediated through two types of receptor complexes.. Cytokine Growth Factor Rev 21(5):353-63 PMID: 20864382
- 7. Otkjaer K et al.. 2005. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.. Br J Dermatol 153(5):911-8 PMID: 16225599
- 8. Wang M et al.. 2005. Interleukin-24 and its receptors.. Immunology 114(2):166-70 PMID: 15667561
